Latanoprost And Timolol Accord-Uk (Timolol Maleate, Latanoprost)

Latanoprost and timolol combination is indicated for conditions that require reduction of intra‑ocular pressure.

• Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression.
• Ocular hypertension: lowers eye pressure to prevent conversion to glaucoma.
• Pseudoexfoliative glaucoma: helps control pressure when monotherapy is insufficient.

• Timolol maleate acts as a non‑selective β‑adrenergic blocker, decreasing aqueous humor production by inhibiting cAMP formation in the ciliary epithelium. Latanoprost, a prostaglandin F2α analog, binds to FP receptors in the iris‑ciliary body, remodeling extracellular matrix and enhancing uveoscleral outflow of aqueous humor, providing sustained pressure control throughout the dosing interval.

The most frequently reported ocular and systemic reactions to the timolol/latanoprost eye drop combination are listed below.

Common Side Effects

• Eye irritation: transient burning or stinging after instillation.
• Blurred vision: temporary reduction in visual clarity.
• Conjunctival hyperemia: mild redness of the eye.
• Increased eyelash growth: longer, thicker lashes may appear.

Serious or Rare Side Effects

• Allergic eye reaction: swelling, itching, or severe redness requiring medical attention.
• Sudden loss of vision: abrupt visual impairment that should be reported immediately.
• Systemic beta‑blocker effects: bradycardia, hypotension, or bronchospasm in susceptible patients.

Before prescribing Latanoprost And Timolol Accord-Uk, clinicians should consider the following precautions.

• Pregnancy: evaluate risk‑benefit and consult obstetric guidance.
• Breastfeeding: assess potential exposure to infant and discuss with healthcare provider.
• Respiratory disease: use cautiously in patients with asthma or COPD due to beta‑blocker activity.
• Cardiovascular conditions: avoid in severe bradycardia, heart block, or uncontrolled heart failure.
• Contact lens wearers: remove lenses before instillation and wait before reinserting.
• Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost/timolol eye drops may interact with other medicines; notable interactions include:

Major Interactions (Avoid)

• Other ocular beta‑blockers: additive systemic beta‑blockade increasing risk of bradycardia.
• Systemic non‑selective beta‑blockers (e.g., propranolol): may enhance cardiovascular depression.
• Prostaglandin‑synthesizing agents: may reduce efficacy of latanoprost.

Moderate Interactions (Monitor Closely)

• Anticholinergic eye drops: possible reduced pupil dilation.
• Adrenergic agonist eye drops (e.g., phenylephrine): may counteract pressure‑lowering effect.
• Systemic antihypertensives: monitor blood pressure for additive lowering.
• NSAID eye drops: may increase risk of ocular irritation.